Methods of treating platinum -sensitive recurrecent ovarian cancer with 4-iodo-3-nitrobenzamide in combination with an anti-metabolite and a platinum compound

Details for Australian Patent Application No. 2010249295 (hide)

Owner Bipar Sciences, Inc.

Inventors Bradley, Charles

Agent A J Park

Pub. Number AU-A-2010249295

Priority 61/351,785 04.06.10 US

Filing date 13 December 2010

Wipo publication date 22 December 2011

International Classifications

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/282 (2006.01)

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

6 January 2011 Complete Application Filed

  Priority application(s): 61/351,785 04.06.10 US

22 December 2011 Application Open to Public Inspection

  Published as AU-A-2010249295

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010249296-Introducer with extension and looped wire

2010249294-Method to improve perforating effectiveness using a charge perforator